Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings.
Shi Ying TanHeather CroninStephen ByrneAdrian O'DonovanAntoinette TuthillPublished in: Irish journal of medical science (2021)
A significant number of people with type 2 diabetes who should have been prescribed aspirin for secondary prevention were not receiving it at the time of study assessment. In contrast, a substantial proportion who did not meet criteria for aspirin use was prescribed it for primary prevention.
Keyphrases
- low dose
- cardiovascular disease
- type diabetes
- cardiovascular events
- antiplatelet therapy
- primary care
- healthcare
- magnetic resonance
- anti inflammatory drugs
- acute coronary syndrome
- coronary artery disease
- percutaneous coronary intervention
- glycemic control
- computed tomography
- emergency department
- cardiovascular risk factors
- adipose tissue
- magnetic resonance imaging
- chronic pain
- atrial fibrillation